← Browse by Condition
Medical Condition
graft versus host disease
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2
NCT05675930 Phase 2
Recruiting
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Enrollment
44 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT07356245 Phase 2
Recruiting
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Enrollment
44 pts
Location
United States
Sponsor
Jonathan Brammer
NCT00603330 Phase 2
Recruiting
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
Enrollment
100 pts
Location
Belgium, Netherlands
Sponsor
University of Liege
NCT07246031 Phase 2
Recruiting
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
Enrollment
50 pts
Location
China
Sponsor
BioPhoenix Co., Ltd.
NCT05621733
Recruiting
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Enrollment
127 pts
Location
South Korea
Sponsor
Novartis Pharmaceuticals